vs

Side-by-side financial comparison of Caledonia Mining Corp Plc (CMCL) and Fulgent Genetics, Inc. (FLGT). Click either name above to swap in a different company.

Fulgent Genetics, Inc. is the larger business by last-quarter revenue ($71.1M vs $46.9M, roughly 1.5× Caledonia Mining Corp Plc). On growth, Caledonia Mining Corp Plc posted the faster year-over-year revenue change (13.8% vs -3.2%). Over the past eight quarters, Caledonia Mining Corp Plc's revenue compounded faster (17.1% CAGR vs 0.1%).

Hochschild Mining plc is a leading British-based silver and gold mining business operating in North, Central, and South America. It is headquartered in Lima, Peru, with a corporate office in London, is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. The main shareholder is the Peruvian businessman Eduardo Hochschild.

Fulgent Genetics, Inc. is a molecular diagnostics technology firm that develops and offers genetic testing services including carrier screening, oncology testing, infectious disease detection, and hereditary condition analysis, serving clinical providers, pharma firms, research institutions and public health groups primarily in North America.

CMCL vs FLGT — Head-to-Head

Bigger by revenue
FLGT
FLGT
1.5× larger
FLGT
$71.1M
$46.9M
CMCL
Growing faster (revenue YoY)
CMCL
CMCL
+17.0% gap
CMCL
13.8%
-3.2%
FLGT
Faster 2-yr revenue CAGR
CMCL
CMCL
Annualised
CMCL
17.1%
0.1%
FLGT

Income Statement — Q3 FY2024 vs Q1 FY2026

Metric
CMCL
CMCL
FLGT
FLGT
Revenue
$46.9M
$71.1M
Net Profit
$3.3M
Gross Margin
41.2%
30.2%
Operating Margin
18.6%
21.1%
Net Margin
7.0%
Revenue YoY
13.8%
-3.2%
Net Profit YoY
-33.3%
EPS (diluted)
$0.13
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMCL
CMCL
FLGT
FLGT
Q1 26
$71.1M
Q4 25
$83.3M
Q3 25
$84.1M
Q2 25
$81.8M
Q1 25
$73.5M
Q4 24
$76.2M
Q3 24
$46.9M
$71.7M
Q2 24
$50.1M
$71.0M
Net Profit
CMCL
CMCL
FLGT
FLGT
Q1 26
Q4 25
$-23.4M
Q3 25
$-6.6M
Q2 25
$-19.0M
Q1 25
$-11.5M
Q4 24
$-5.9M
Q3 24
$3.3M
$-14.6M
Q2 24
$10.2M
$-8.7M
Gross Margin
CMCL
CMCL
FLGT
FLGT
Q1 26
30.2%
Q4 25
39.1%
Q3 25
42.2%
Q2 25
42.1%
Q1 25
38.6%
Q4 24
41.8%
Q3 24
41.2%
37.3%
Q2 24
45.8%
37.3%
Operating Margin
CMCL
CMCL
FLGT
FLGT
Q1 26
21.1%
Q4 25
-43.5%
Q3 25
-18.3%
Q2 25
-24.1%
Q1 25
-26.9%
Q4 24
-21.2%
Q3 24
18.6%
-23.8%
Q2 24
32.2%
-26.6%
Net Margin
CMCL
CMCL
FLGT
FLGT
Q1 26
Q4 25
-28.1%
Q3 25
-7.9%
Q2 25
-23.2%
Q1 25
-15.7%
Q4 24
-7.7%
Q3 24
7.0%
-20.4%
Q2 24
20.3%
-12.3%
EPS (diluted)
CMCL
CMCL
FLGT
FLGT
Q1 26
$0.04
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$0.13
Q2 24
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMCL
CMCL
FLGT
FLGT
Cash + ST InvestmentsLiquidity on hand
$7.2M
$23.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$231.0M
Total Assets
$339.7M
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMCL
CMCL
FLGT
FLGT
Q1 26
$23.4M
Q4 25
$50.2M
Q3 25
$117.6M
Q2 25
$87.9M
Q1 25
$67.3M
Q4 24
$55.1M
Q3 24
$7.2M
$58.0M
Q2 24
$15.4M
$65.1M
Stockholders' Equity
CMCL
CMCL
FLGT
FLGT
Q1 26
Q4 25
$1.1B
Q3 25
$1.1B
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$231.0M
$1.1B
Q2 24
$231.1M
$1.1B
Total Assets
CMCL
CMCL
FLGT
FLGT
Q1 26
$1.2B
Q4 25
$1.2B
Q3 25
$1.2B
Q2 25
$1.2B
Q1 25
$1.2B
Q4 24
$1.2B
Q3 24
$339.7M
$1.2B
Q2 24
$338.5M
$1.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMCL
CMCL
FLGT
FLGT
Operating Cash FlowLast quarter
$4.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.40×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMCL
CMCL
FLGT
FLGT
Q1 26
Q4 25
$-78.1M
Q3 25
$11.1M
Q2 25
$-30.2M
Q1 25
$-4.4M
Q4 24
$25.0M
Q3 24
$4.6M
$-15.5M
Q2 24
$19.1M
$4.3M
Free Cash Flow
CMCL
CMCL
FLGT
FLGT
Q1 26
Q4 25
$-83.1M
Q3 25
$5.1M
Q2 25
$-37.0M
Q1 25
$-9.1M
Q4 24
$21.2M
Q3 24
$-35.0M
Q2 24
$-8.7M
FCF Margin
CMCL
CMCL
FLGT
FLGT
Q1 26
Q4 25
-99.7%
Q3 25
6.0%
Q2 25
-45.2%
Q1 25
-12.5%
Q4 24
27.9%
Q3 24
-48.8%
Q2 24
-12.2%
Capex Intensity
CMCL
CMCL
FLGT
FLGT
Q1 26
Q4 25
6.0%
Q3 25
7.2%
Q2 25
8.3%
Q1 25
6.4%
Q4 24
5.0%
Q3 24
27.2%
Q2 24
18.2%
Cash Conversion
CMCL
CMCL
FLGT
FLGT
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.40×
Q2 24
1.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons